Does Shatavari affect quality of life and reproductive health of females?
Phase 2
- Registration Number
- CTRI/2022/05/042463
- Lead Sponsor
- ihar Ranjan Pradhan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women who have attained menopause
Able to take the drug orally and comply with study procedures;
Exclusion Criteria
In shock,
Consumption of other oral probiotic supplements during the trial;
Patients with severe underlying diseases that affects survival, including uncontrolled malignant tumor with multiple metastases that cannot be resected,
Blood diseases,
Dyscrasia,
Active bleeding,
Severe malnutrition
Patients allergic to systemic enzyme supplements;
Patients facing imminent death in the opinion of the clinical team;
Patients with Hb less than 10 g/dl;
Patients who have participated in any other clinical study within 2 weeks prior to randomization
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method